Bong MR, Di Cesare PE: Stiffness after total knee arthroplasty. Journal of the American Academy of Orthopaedic Surgeons. 2004, 12: 164-171.
Laskin RS, Beksac B: Stiffness after total knee arthroplasty. Journal of Arthroplasty. 2004, 19: 41-46.
Yercan HS, Sugun TS, Bussiere C, Ait Si Selmi T, Davies A, Neyret P: Stiffness after total knee arthroplasty: prevalence, management and outcomes. Knee. 2006, 13: 111-117.
Kim J, Nelson CL, Lotke PA: Stiffness after total knee arthroplasty. Prevalence of the complication and outcomes of revision. Journal of Bone & Joint Surgery American. 2004, 86: 1479-1484.
Anouchi YS, McShane M, Kelly F, Elting J, Stiehl J: Range of motion in total knee replacement. Clinical Orthopaedics & Related Research. 1996, 331: 87-92.
Diduch DR, Scuderi GR, Scott WN, Insall JN, Kelly MA: The efficacy of arthroscopy following total knee replacement. Arthroscopy. 1997, 13: 166-171.
Markel DC, Luessenhop CP, Windsor RE, Sculco TA: Arthroscopic treatment of peripatellar fibrosis after total knee arthroplasty. Journal of Arthroplasty. 1996, 11: 293-297.
Mont MA, Serna FK, Krackow KA, Hungerford DS: Exploration of radiographically normal total knee replacements for unexplained pain. Clinical Orthopaedics & Related Research. 1996, 331: 216-220.
Nicholls DW, Dorr LD: Revision surgery for stiff total knee arthroplasty. Journal of Arthroplasty. 1990, 5 (Suppl): S73-7.
Ries MD, Badalamente M: Arthrofibrosis after total knee arthroplasty. Clinical Orthopaedics & Related Research. 2000, 380: 177-183.
Parvizi J, Tarity TD, Steinbeck MJ, Politi RG, Joshi A, Purtill JJ, Sharkey PF: Management of stiffness following total knee arthroplasty. Journal of Bone and Joint Surgery. 2006, 88: 175-181.
Furia JP, Pellegrini VD: Heterotopic ossification following primary total knee arthroplasty [see comment]. Journal of Arthroplasty. 1995, 10: 413-419.
Freeman TA, Parvizi J, Della Valle C, Steinbeck MJ: Mast cells and hypoxia drive tissue metaplasia and heterotopic ossification in idiopathic arthrofibrosis. Fibrogenesis and Tissue Repair. 2009, Submitted
Wynn TA: Fibrotic disease and the th1/th2 paradigm. Nature Reviews Immunology. 2004, 4: 583-594.
Abe R, Donnelly SC, Peng T, Bucala R, Metz CN: Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. Journal of Immunology. 2001, 166: 7556-7562.
Stramer BM, Mori R, Martin P: The inflammation-fibrosis link? A Jekyll and Hyde role for blood cells during wound repair. Journal of Investigative Dermatology. 2007, 127: 1009-1017.
Martin P, Leibovich SJ: Inflammatory cells during wound repair: the good, the bad and the ugly. Trends in Cell Biol. 2005, 15: 599-607.
Baran CP, Zeigler MM, Tridandapani S, Marsh CB: The role of ROS and RNS in regulating life and death of blood monocytes. Current Pharmaceutical Design. 2004, 10: 855-866.
Cochrane AL, Ricardo SD: Oxidant stress and regulation of chemokines in the development of renal interstitial fibrosis. Contributions to Nephrology. 2003, 139: 102-119.
Diamond JR, Ricardo SD, Klahr S: Mechanisms of interstitial fibrosis in obstructive nephropathy. Seminars in Nephrology. 1998, 18: 594-602.
Ferrini MG, Vernet D, Magee TR, Shahed A, Qian A, Rajfer J, Gonzalez-Cadavid NF: Antifibrotic role of inducible nitric oxide synthase. Nitric Oxide. 2002, 6: 283-294.
Marsh CB, Kelley TW, Graham MM, Dong C, Goldschmidt-Clermont PJ: Monocytes may regulate tissue fibrosis. Chest. 2001, 120: 15S-16S.
Poli G: Pathogenesis of liver fibrosis: role of oxidative stress. Molecular Aspects of Medicine. 2000, 21: 49-98.
Poli G, Parola M: Oxidative damage and fibrogenesis. Free Radical Biology & Medicine. 1997, 22: 287-305.
Ricardo SD, Diamond JR: The role of macrophages and reactive oxygen species in experimental hydronephrosis. Seminars in Nephrology. 1998, 18: 612-621.
Swindle EJ, Hunt JA, Coleman JW: A comparison of reactive oxygen species generation by rat peritoneal macrophages and mast cells using the highly sensitive real-time chemiluminescent probe pholasin: inhibition of antigen-induced mast cell degranulation by macrophage-derived hydrogen peroxide. Journal of Immunology. 2002, 169: 5866-5873.
Puxeddu I, Piliponsky AM, Bachelet I, Levi-Schaffer F: Mast cells in allergy and beyond. International Journal of Biochemistry and Cell Biology. 2003, 35: 1601-1607.
Murrell GA: The role of the fibroblast in Dupuytren's contracture. Hand Clinics. 1991, 7: 669-680.
Murrell GA: Scientific comment. Basic science of Dupuytren's disease. Annales de Chirurgie de la Main et du Membre Superieur. 1992, 11: 355-361.
Murrell GA: An insight into Dupuytren's contracture. Annals of the Royal College of Surgeons of England. 1992, 74: 156-160.
Yi IS, Johnson G, Moneim MS: Etiology of Dupuytren's disease. Hand Clinics. 1999, 15: 43-51.
Cracowski J-L: Isoprostanes as a tool to investigate oxidative stress in scleroderma spectrum disorders--advantages and limitations. Rheumatology. 2006, 45: 922-923.
Sambo P, Baroni SS, Luchetti M, Paroncini P, Dusi S, Orlandini G, Gabrielli A: Oxidative stress in scleroderma: maintenance of scleroderma fibroblast phenotype by the constitutive up-regulation of reactive oxygen species generation through the NADPH oxidase complex pathway [see comment]. Arthritis & Rheumatism. 2001, 44: 2653-2664.
Kruidenier L, Kuiper I, Van Duijn W, Mieremet-Ooms MA, van Hogezand RA, Lamers CB, Verspaget HW: Imbalanced secondary mucosal antioxidant response in inflammatory bowel disease. Journal of Pathology. 2003, 201: 17-27.
Risques RA, Rabinovitch PS, Brentnall TA: Cancer surveillance in inflammmatory bowel disease: new molecular approaches. Current Opinion in Gastroenterology. 2006, 22: 382-390.
Harrison JE, Schultz J: Studies on the chlorinating activity of myeloperoxidase. Journal of Biological Chemistry. 1976, 251: 1371-1374.
Halliwell B: Oxidative stress and cancer: have we moved forward?. Biochem J. 2007, 401: 1-11.
Heijnem HF, van Donselaar E, Slot JW, Fries DM, Blachard-Fillion B, Hodara R, Lightfoot R, Polydoro M, Spielberg DL, et al: Subcellular localization of tyrosine-nitrated proteins is dictated by reactive oxygen species generating enzymes and by proximity to nitric oxide synthase. Free Radical Biology & Medicine. 2006, 40: 1903-1913.
van Dalen CJ, Winterbourn CC, Senthilmohan R, Kettle AJ: Nitrite as a substrate and inhibitor of myeloperoxidase. Implications for nitration and hypochlorous acid production at sites of inflammation. J Biol Chem. 2000, 275: 11638-11644.
Takeshita J, Byun J, Nhan TQ, Pritchard DK, Pennathur S, Schwartz SM, Chait A, Heinecke JW: Myeloperoxidase generates 5-chlorouracil in human atherosclerotic tissue: a potential pathway for somatic mutagenesis by macrophages. J Biol Chem. 2006, 281: 3096-3104.
Henderson JP, Byun J, Takeshita J, Heinecke JW: Phagocytes produce 5-chlorouracil and 5-bromouracil, two mutagenic products of myeloperoxidase, in human inflammatory tissue. J Biol Chem. 2003, 278: 23522-23528.
Fitzgerald AM, Kirkpatrick JJ, Naylor IL: Dupuytren's disease. The way forward?. Journal of Hand Surgery British. 1999, 24: 395-399.
Murrell GA, Hueston JT: Aetiology of Dupuytren's contracture. Australian & New Zealand Journal of Surgery. 1990, 60: 247-252.
Wynn TA: Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. Journal of Clinical Investigation. 2007, 117: 524-529.
Murakami S, Muneta T, Furuya K, Saito I, Miyasaka N, Yamamoto H: Immunohistologic analysis of synovium in infrapatellar fat pad after anterior cruciate ligament injury. The American Journal of Sports Medicine. 1995, 23: 763-768.
Bosch U, Zeichen J, Skutek M, Haeder L, van Griensven M: Arthrofibrosis is the result of a T cell mediated immune response. Knee Surgery, Sports Traumatology, Arthroscopy. 2001, 9: 282-289.
Howard PS, Renfrow D, Schechter NM, Kucich U: Mast cell chymase is a possible mediator of neurogenic bladder fibrosis. Neurourology & Urodynamics. 2004, 23: 374-382.
Kaplan FS, Glaser DL, Hebela N, Shore EM: Heterotopic ossification. Journal of the American Academy of Orthopaedic Surgeons. 2004, 12: 116-125.
Kubiak EN, Moskovich R, Errico TJ, Di Cesare PE: Orthopaedic management of ankylosing spondylitis. Journal of the American Academy of Orthopaedic Surgeons. 2005, 13: 267-278.
Liu K, Tripp S, Layfield LJ: Heterotopic ossification: review of histologic findings and tissue distribution in a 10-year experience. Pathology, Research & Practice. 2007, 203: 633-640.
Rifas L: T-cell cytokine induction of BMP-2 regulates human mesenchymal stromal cell differentiation and mineralization. Journal of Cellular Biochemistry. 2006, 98: 706-714.
Steiner I, Kasparova P, Kohout A, Dominik J: Bone formation in cardiac valves: a histopathological study of 128 cases. Virchows Archiv. 2007, 450: 653-657.
Darley-Usmar V, Wiseman H, Halliwell B: Nitric oxide and oxygen radicals: a question of balance. FEBS Letters. 1995, 369: 131-135.
Brown GC, Borutaite V: Interactions between nitric oxide, oxygen, reactive oxygen species and reactive nitrogen species. Biochem Society Transactions. 2006, 34: 953-956.
Hurst JK, Barrette WC: Leukocytic oxygen activation and microbicidal oxidative toxins. Critical Reviews in Biochemistry & Molecular Biology. 1989, 24: 271-328.
Daumer KM, Khan AU, Steinbeck MJ: Chlorination of pyridinium compounds. Possible role of hypochlorite, N-chloramines, and chlorine in the oxidation of pyridinoline cross-links of articular cartilage collagen type II during acute inflammation. Journal of Biological Chemistry. 2000, 275: 34681-34692.
Steinbeck MJ, Nesti LJ, Sharkey PF, Parvizi J: Myeloperoxidase and chlorinated peptides in osteoarthritis: potential biomarkers of the disease. J Ortho Res. 2007, 25: 1128-1135.
Reynolds WF, Patel K, Pianko S, Blatt LM, Nicholas JJ, McHutchison JG: A genotypic association implicates myeloperoxidase in the progression of hepatic fibrosis in chronic hepatitis c virus infection. Genes and Immunity. 2002, 3: 345-349.
Reynolds WF, Sermet-Gaudelus I, Gausson V, Feuillet M-N, Bonnefont J-P, Descamps-Latscha B, Witko-Sarsat V: Myeloperoxidase promoter polymorphism -463G is associated with more severe clinical expression of cystic fibrosis pulmonary disease. Mediators of Inflammation. 2006, 36735: 1-8.
Blom IE, Goldschmeding R, Leask A: Gene regulation of connective tissue growth factor: new targets for antifibrotic therapy?. Matrix Biology. 2002, 21: 473-482.
Schafer M, Werner S: Oxidative stress in normal and impaired wound repair. Pharmacological Research. 2008, 58: 165-171.
Hazra TK, Das A, Das S, Choudhury S, Kow YW, Roy R: Oxidative DNA damage repair in mammalian cells: a new perspective. DNA Repair. 2007, 6: 470-480.
Mustacich D, Powis G: Thioredoxin reductase. Biochem J. 2000, 346: 1-8.
Yu YP, Yu G, Tseng G, Cieply K, Nelson J, Defrances M, Zarnegar R, Michalopoulos G, Luo J-H: Glutathione peroxidase 3, deleted or methylated in prostate cancer, suppresses prostate cancer growth and metastasis. Cancer Res. 2007, 67: 8043-8050.
Scanzello CR, Plaas A, Crow MK: Innate immune system activation in osteoarthritis: is osteoarthritis a chronic wound?. Current Opinion in Rheumatology. 2008, 20: 565-572.
Jones KL, Tarochione-Utt KD: DNA methylation in bovine adult and fetal fibroblast cells. Cloning & Stem Cells. 2004, 6: 259-266.